Although our study focused on the heart, our data also showed that DCLK1 deletion in macrophages or pharmacological inhibition significantly reversed hyperlipidemia profile in HFD-fed mice, suggesting that DCLK1-mediated macrophage activation plays a role in lipid metabolism. This evidence concerns the gene DCLK1 and hyperlipidemia.